MENU
PRME
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Prime Medicine (PRME) Ownership - Who owns Prime Medicine?

Prime Medicine Inc is a biotechnology company committed to delivering genetic therapies to address diseases by deploying gene editing technology, Prime Editing... Show more

Profile

Industry
N/A
Address
21 Erie Street
Phone
+1 617 564-0013
Employees
234
Web
https://www.primemedicine.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
599.3M
P/E Ratio
N/A
Total Cash
101.75M
Projected Growth
N/A
Total Debt
119.74M
Revenue
4.96M
Risk (Beta)
2.61
Dividend Yield
N/A
Total Cash/Share
0.56
Total Debt/Equity
N/A
Revenue/Share
0.04 USD as % of share price

Fundamentals

PRME
Capitalization
599M
P/E Ratio
N/A
Risk (Beta)
2.61
Dividend Yield
N/A
Total Cash
102M
Total Cash/Share
0.56
Total Debt
120M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0.04%
Revenue
4.96M
ROE
N/A
Book Value
60.9M
P/B Ratio
3.70
Cash Flow
N/A
Earnings
-1.56
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
2K
Current Ratio
3.56
Current Revenue Per Employee
5210.28
Dividends Per Share - Security
N/A
EBITDA
-197.38M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-73.98
Shares Held By Institutions
216M
Shares Outstanding - Current
181M
Total Liabilities
218M
Total Volume MTD
N/A
Value
N/A
Gain YTD
14.041
View a ticker or compare two or three
PRME
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period.
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
21 Erie Street
Phone
+1 617 564-0013
Employees
234
Web
https://www.primemedicine.com